Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2026-03-02 | Was: 2026-02-16 |
| Drug Identification Number | 02529599 | 02529599 |
| Brand name | AZACITIDINE FOR INJECTION | AZACITIDINE FOR INJECTION |
| Common or Proper name | AZACITIDINE FOR INJECTION | AZACITIDINE FOR INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | AZACITIDINE | AZACITIDINE |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | POWDER FOR SUSPENSION | POWDER FOR SUSPENSION |
| Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
| Packaging size | 1LYVI | 1LYVI |
| Additional packaging sizes | ||
| ATC code | L01BC | L01BC |
| ATC description | ANTIMETABOLITES | ANTIMETABOLITES |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | ||
| Actual start date | 2026-02-16 | 2026-02-16 |
| Estimated end date (Changed) | Updated to: 2026-03-06 | Was: 2026-02-27 |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |